Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
International Journal of Colorectal Disease|May 1, 1994
Total rectal resection and colo-anal anastomosis with colonic reservoir for low rectal cancerE Leo, F Belli, M T Baldini, et al.
Tumori|June 30, 1989
A phase II study of the administration of recombinant interleukin 2 (rIL-2) plus lymphokine activated killer (LAK) cells in stage IV melanoma patientsN Cascinelli, F Belli, S Marchini, et al.
The Review of Scientific Instruments|August 3, 2017
Extremely broadband single-shot cross-correlation frequency-resolved optical gating using a transient grating as gate and dispersive elementH Valtna-Lukner, F Belli, A Ermolov, et al.
Cancer Research|February 2, 1999
A superagonist variant of peptide MART1/Melan A27-35 elicits anti-melanoma CD8+ T cells with enhanced functional characteristics: implication for more effective immunotherapyL Rivoltini, P Squarcina, D J Loftus, et al.
Diseases of the Colon and Rectum|January 1, 1997
Distal intramural spread in adenocarcinoma of the lower third of the rectum treated with total rectal resection and coloanal anastomosisS Andreola, E Leo, F Belli, et al.
Cancer Immunology, Immunotherapy : CII|May 1, 1993
Adoptive immunotherapy of advanced melanoma patients with interleukin-2 (IL-2) and tumor-infiltrating lymphocytes selected in vitro with low doses of IL-2F Arienti, F Belli, L Rivoltini, et al.
Annals of Surgery|January 1, 1987
A reappraisal of oophorectomy in carcinoma of the breastU Veronesi, N Cascinelli, M Greco, et al.
Cancer|January 15, 1994
Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma-interferon, and melphalanM Vaglini, F Belli, M Ammatuna, et al.
International Journal of Cancer|May 15, 1988
In vivo activation of lymphocytes in melanoma patients receiving escalating doses of recombinant interleukin 2C Gambacorti-Passerini, M Radrizzani, R Marolda, et al.
International Journal of Cancer|November 28, 2000
T cell responses in colorectal cancer patients: evidence for class II HLA-restricted recognition of shared tumor-associated antigensA J Bremers, S Andreola, E Leo, et al.
Pageof 13